Study in Subjects With Light Chain (AL) Amyloidosis
Status:
Terminated
Trial end date:
2018-05-30
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the long-term safety and efficacy of NEOD001 in
subjects with AL amyloidosis who have completed Study NEOD001-201.